Aberdeen Royal Infirmary adopt ZedScan

Monday 30th July 2018

Scottish cervical cancer charity funds the introduction of ZedScanto Aberdeen Royal Infirmary

The Michelle Henderson Cervical Cancer Trust has provided the funding for the purchase of two ZedScan devices at Aberdeen Royal Infirmary’s colposcopy unit, to help prevent women developing cervical cancer.

ZedScan is a unique adjunct diagnostic device that uses Electrical Impendence Spectroscopy (EIS) technology to identify cell changes that cannot always be seen during standard colposcopy. Changes in the cells of the cervix can lead to cervical cancer, but early detection of cell abnormalities and appropriate treatment can prevent cervical cancer from developing.

Michelle was just 26 when she was diagnosed with cervical cancer in 2010. The diagnosis came as a shock to her whole family including her father, ex-Scotland football legend William “Willie” Henderson. Tragically, Michelle died of the disease just two years later, on her 28th birthday.

Since his daughter’s diagnosis, Willie has been a key fundraiser for the Michelle Henderson Cervical Cancer Trust. He says, “Michelle wanted to put the Trust in place to ensure that gynaecology departments had access to the equipment they need to ensure other women did not have to go through what she did and to potentially save their lives.” It is in her memory that the charity is supporting the purchase of the ZedScan devices for Aberdeen Royal Infirmary.

The colposcopy unit at Aberdeen sees around 2500 new and returning patients each year and is led by Maggie Cruickshank, Professor of Gynaecology at the University of Aberdeen and one of the leading experts in HPV (Human Papillomavirus), which causes 99% of cervical cancers[i].

“We wanted to invest in something which could really make a difference.  Willie offered to fund new equipment from the Michelle Henderson Trust, established by his daughter Michelle before she died from cervical cancer, aged just 28.  Here in the North-East of Scotland, our patients often travel long distances to our colposcopy clinic based in Aberdeen – as much as 300 miles from the Orkney and Shetland Islands. The ability of ZedScan to increase the number of high grade cases that we detect at first visit but also to confirm normality, can help reduce return visits for women.  We hope to see an increase in ‘one stop’ visits to our service and extra reassurance for the women who attend the Women’s Day Clinic.”

The Aberdeen University Research Centre for Women’s Health has led on research into improving the care of women with abnormal smears and HPV-related diseases for over 30 years. Having evaluated ZedScan in the unit, the findings were comparable to published data which shows 96.2% of all high-grade abnormalities are identified when ZedScan is used, helping to support better patient management.

 

[i] https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vaccine/

For media enquiries, please contact:

Stephanie Oxley, Onyx Health                                    

Tel: +44 7788 294 439                                                

E-mail: soxley@onyxhealth.com

News